Author:
Chiaravalli Anna Maria,D’Amato Pascarella Rebecca
Publisher
Springer International Publishing
Reference11 articles.
1. Bellizzi, A. M. (2020). Immunohistochemistry in the diagnosis and classification of neuroendocrine neoplasms: what can brown do for you?. Human Pathology, 96, 8–33.
2. Briest, F., & Grabowski, P. (2015). The p53 network astherapeutic target in gastroenteropancreatic neuroendocrine neoplasms. Cancer Treatment Reviews, 41(5), 423–430.
3. Bykov, V. J., Eriksson, S. E., Bianchi, J., & Wiman, K. G. (2018). Targeting mutant p53 for efficient cancer therapy. Nature Reviews Cancer, 18(2), 89.
4. Hayat, M. A. (2002). Cell proliferating antigens. In Microscopy, immunohistochemistry, and antigen retrieval methods: For light and electron microscopy (pp. 233–259). Springer, Boston.
5. Hientz, K., Mohr, A., Bhakta-Guha, D., & Efferth, T. (2017). The role of p53 in cancer drug resistance and targeted chemotherapy. Oncotarget, 8(5), 8921.